A broadly neutralizing antibody protects Syrian hamsters against SARS-CoV-2 Omicron challenge

The strikingly high transmissibility and antibody evasion of SARS-CoV-2 Omicron variants have posed great challenges to the efficacy of current vaccines and antibody immunotherapy. Here, we screen 34 BNT162b2-vaccinees and isolate a public broadly neutralizing antibody ZCB11 derived from the IGHV1-5...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Biao, Zhou, Runhong, Tang, Bingjie, Chan, Jasper Fuk-Woo, Luo, Mengxiao, Peng, Qiaoli, Yuan, Shuofeng, Liu, Hang, Mok, Bobo Wing-Yee, Chen, Bohao, Wang, Pui, Poon, Vincent Kwok-Man, Chu, Hin, Chan, Chris Chung-Sing, Tsang, Jessica Oi-Ling, Chan, Chris Chun-Yiu, Au, Ka-Kit, Man, Hiu-On, Lu, Lu, To, Kelvin Kai-Wang, Chen, Honglin, Yuen, Kwok-Yung, Dang, Shangyu, Chen, Zhiwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9223271/
https://www.ncbi.nlm.nih.gov/pubmed/35739114
http://dx.doi.org/10.1038/s41467-022-31259-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9223271/
https://www.ncbi.nlm.nih.gov/pubmed/35739114
http://dx.doi.org/10.1038/s41467-022-31259-7

Ejemplares similares